Essex Bio-Technology Income Statement

Financials in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,814	1,670	1,737	1,318	1,638
Revenue Growth (YoY)	8.62%	-3.87%	31.82%	-19.54%	67.43%
Cost of Revenue	195.92	171.15	174.94	128.38	241.89
Gross Profit	1,618	1,499	1,562	1,189	1,396
Selling, General & Admin	1,207	1,148	1,229	914.19	989.71
Other Operating Expenses	-6.3	-11.44	-18.51	-26.83	12.24
Operating Expenses	1,201	1,144	1,210	887.36	1,002
Operating Income	416.78	354.79	351.57	301.97	393.82
Interest Expense	-7.82	-6.09	-11.21	-11.47	-9.22
Interest & Investment Income	11.83	11.45	12.34	8.88	9.86
Earnings From Equity Investments	-0.16	-2.91	-1.64	-0.19	-
EBT Excluding Unusual Items	420.63	357.24	351.06	299.18	394.46
Impairment of Goodwill	-	-	-	-25.83	-
Asset Writedown	-8.47	-2.88	-5.05	-13.01	-
Legal Settlements	-10.16	21.14	-	-	-
Other Unusual Items	12.66	-	-	-	-
Pretax Income	414.66	375.5	346.01	260.34	394.46
Income Tax Expense	96.57	68.28	70.75	34.93	48.49
Net Income	318.09	307.22	275.26	225.41	345.97
Net Income to Common	318.09	307.22	275.26	225.41	345.97
Net Income Growth	3.54%	11.61%	22.11%	-34.85%	58.03%
Shares Outstanding (Basic)	567	567	570	574	577
Shares Outstanding (Diluted)	567	582	596	599	602
Shares Change (YoY)	-2.63%	-2.24%	-0.62%	-0.43%	-0.21%
EPS (Basic)	0.56	0.54	0.48	0.39	0.60
EPS (Diluted)	0.56	0.53	0.47	0.38	0.58
EPS Growth	5.49%	13.38%	22.52%	-34.14%	55.93%
Free Cash Flow	198.81	324.07	318.17	293.29	319.12
Free Cash Flow Per Share	0.35	0.56	0.53	0.49	0.53
Dividend Per Share	0.140	0.120	0.090	0.065	0.095
Dividend Growth	16.67%	33.33%	38.46%	-31.58%	90.00%
Gross Margin	89.20%	89.75%	89.93%	90.26%	85.23%
Operating Margin	22.98%	21.25%	20.24%	22.92%	24.05%
Profit Margin	17.54%	18.40%	15.85%	17.11%	21.13%
Free Cash Flow Margin	10.96%	19.41%	18.32%	22.26%	19.49%
EBITDA	467.9	400.71	402.67	336.24	419.02
EBITDA Margin	25.80%	24.00%	23.18%	25.52%	25.59%
D&A For EBITDA	51.12	45.92	51.09	34.27	25.2
EBIT	416.78	354.79	351.57	301.97	393.82
EBIT Margin	22.98%	21.25%	20.24%	22.92%	24.05%
Effective Tax Rate	23.29%	18.18%	20.45%	13.42%	12.29%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.